Neuromyelitis Optica

Neuromyelitis optica is an inflammatory disease characterized by selective demyelination of the spinal cord and optic nerves. Discover the latest research on neuromyelitis optica here.

June 25, 2020

The Importance of Thiopurine S-Methyltransferase Gene Analysis Before Azathioprine Therapy

Clinical Neuropharmacology
Gürkan GürbüzAycan Ünalp
June 26, 2020

Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease

Multiple Sclerosis : Clinical and Laboratory Research
Léa LucianiAntoine Nougairède
June 23, 2020

Microglia complement astrocytes in neuromyelitis optica

The Journal of Clinical Investigation
Zahra Moinfar, Scott S Zamvil
June 24, 2020
Comment / Editorial
Open Access

Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis

Multiple Sclerosis and Related Disorders
Sara SalamaMichael Levy
July 3, 2020

Atypical MOG antibody disease presenting with typical multiple sclerosis lesions

Multiple Sclerosis and Related Disorders
Katelyn DolbecPadmaja Sudhakar
June 21, 2020

Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort

Multiple Sclerosis and Related Disorders
Correa-Díaz Edgar PatricioGualotuña Pachacama Wilson Alfredo
June 24, 2020

Anti-myelin oligodendrocyte glycoprotein (MOG) associated disease masquerading as prolonged intractable nausea and vomiting

Multiple Sclerosis and Related Disorders
Allison BlockAhmed Z Obeidat
June 20, 2020
Case Report

Cannabis extract for the treatment of painful tonic spasms in a patient with neuromyelitis optica spectrum disorder: A case report

Multiple Sclerosis and Related Disorders
Nanthaya TisavipatJiraporn Jitprapaikulsan
June 26, 2020

Comparison of Two Iliac Branch Devices and Their Midterm Performance in Maintaining Blood Flow to the Internal Iliac Artery

Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
Spyridon N MylonasJan S Brunkwall
June 26, 2020

Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees

Multiple Sclerosis and Related Disorders
Le H HuaErin E Longbrake
June 23, 2020

Copresence of myasthenia gravis and neuromyelitis optica: 2 case reports

Neurología : publicación oficial de la Sociedad Española de Neurología
R Piñar MoralesF J Barrero Hernández
June 23, 2020

Unilateral Optic Neuritis in Children: Experience of a Tertiary Centre

European Neurology
Rui Duarte ArmindoFilipe Palavra
July 6, 2020

Autoimmune and demyelinating optic neuritis

Archivos de la Sociedad Española de Oftalmología
A García OrtegaB Sanchez-Dalmau
July 1, 2020
Open Access

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2

Practical Neurology
Sophia MichaelSarosh R Irani

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research.

Demyelinating Disorders of the CNS

Demyelinating diseases result in damage to the myelin sheath that surrounds nerves in the brain and spinal cord and can result in neurological conditions such as multiple sclerosis. Here is the latest research on demyelinating disorders of the central nervous system.

Diet and Multiple Sclerosis

A healthy and balanced diet is essential for controlling diseases such as multiple scelrosis. Here are the latest discoveries pertaining to diet and this disease.

Diffuse Myelinoclastic Sclerosis

Diffuse myelinoclastic sclerosis is a neurodegenerative disorder characterized by pseudotumoral demyelinating lesions. It is sometimes considered a variant of multiple sclerosis while other researchers consider it a distinct disease. Find the latest research on diffuse myelinoclastic sclerosis here.

Experimental Autoimmune Encephalomyelitis

Experimental autoimmune encephalomyelitis is a commonly used experimental model for autoimmune central nervous system diseases, most notably multiple sclerosis. Here is the latest research on experimental autoimmune encephalomyelitis.

MS: Therapies

The feed focuses on therapeutic interventions used to treat Multiple Sclerosis.

Microbiome and MS

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research on the influence of the human microbiome on this dymyelinating disorder.

Microglia And CNS Diseases

Microglia are resident macrophages of the CNS. They play a role in scavenging the CNS for plaques, phagocytosis, and extracellular signaling. Here is the latest research on their role in CNS diseases.

© 2020 Meta ULC. All rights reserved